BrainSight AI, a startup focused on brain health, has just raised $5 million in a funding round led by IAN Alpha Fund. Other investors include IvyCap Ventures and Silver Needle. The company plans to use this money to expand its services in major Indian cities and reach smaller cities too.
They also want to get certification from the U.S. Food and Drug Administration (FDA), which will help them enter the U.S. and other markets. BrainSight AI is also looking to explore opportunities in Africa and Southeast Asia, as there’s interest from distributors there. They’ll also develop an app for caregivers to help families who have loved ones with brain disorders.
Based in Bengaluru, BrainSight AI collaborates with over 40 hospitals in India, mainly focusing on treating brain tumor patients. The company is also starting to look at neurological and psychiatric disorders.
BrainSight AI was founded by Laina Emmanuel, an engineer, and Rimjhim Agrawal, who has a PhD in machine learning for psychiatry. They use artificial intelligence and neuroscience to improve the way brain issues are diagnosed, leading to better and quicker care for patients.
Laina Emmanuel, the CEO, expressed her excitement about using connectomics, a field that studies the brain’s connections, to provide personalized brain care. The company’s products include Voxelbox, which helps doctors analyze brain scans, and Snowdrop, an app that helps patients stick to their treatment plans.
Priyank Garg from IAN Alpha Fund praised BrainSight AI, stating that their technology could change how brain disorders are treated for everyone. In 2020, they also received grants from the Biotechnology Industry Research Assistance Council (BIRAC), a government body.
As BrainSight AI continues to grow, they believe they can achieve a $100 million annual revenue goal by expanding in India and globally.
Leave a Reply